Burning Rock Biotech Ltd Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Han Yusheng, was filed 02 Apr 2026.
Burning Rock Biotech Ltd: what insiders have been doing
Insider filings for Burning Rock Biotech Ltd are scarce in the SEC (Form 4) feed, the latest one published on 2 April 2026. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -38.5%Entry US$13.50 · Close at T+90 US$8.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 314,870 shares@ US$17.36100.0% of flowOrdinary Shares (represented by American depositary shares)SEC:0001193125-26-138961:0Canonical exit: 29 Jun 2026 (T+90)
1 of 1 declaration
About Burning Rock Biotech Ltd
Burning Rock Biotech Ltd is a company focused on developing molecular diagnostic solutions for cancer. It is listed on NASDAQ under the ticker BNR.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
